Related Experiment Videos

[Reactions and complications caused by thrombocyte concentrate transfusions]

S M Haĭdukova, S V Vydyborets', N I Kostiukova

Likars'Ka Sprava

|June 21, 2002

The review contains current data on complications developing in the wake of employing thrombocytes concentrate in clinical settings. Complication patterns are submitted, causes thereof are analyzed. Technical aspects are discussed of optimum measures to be implemented in transfusions of the thrombocytes concentrate.

The review contains current data on complications developing in the wake of employing thrombocytes concentrate in clinical settings. Complication patterns are submitted, causes thereof are analyzed. Technical aspects are discussed of optimum measures to be implemented in transfusions of the thrombocytes concentrate.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma.

Experimental oncology·2021

[Experience of using thalidomide in the treatment of patients with multiple myeloma].

Likars'ka sprava·2011

[Prognostic value of tumour cell apoptosis in patients with B-cell non-Hodgkin's lymphoma].

Likars'ka sprava·2004

[Pathophysiological mechanisms of formation of iron deficiency states and modern approaches to administration of oral forms of iron preparations in their prophylaxis and treatment].

Likars'ka sprava·2003

[Clinical use of parenteral preparations of iron].

Likars'ka sprava·2003

[Clinical significance of serum levels of medium size molecules in patients with iron deficiency anemia].

Likars'ka sprava·2002

See all related articles